Nichi-Iko and Eisai devise Japan alliance

Nichi-Iko is set to obtain by 1 April next year all shares in Eisai’s Elmed Eisai value-added generic pharmaceuticals business in Japan, while Nichi-Iko and Elmed Eisai also plan to “integrate their strengths” and co-promote one another’s generic products in the country, as part of a broader, three-part, strategic alliance agreement.